Diagnostic Tests For Liver Disease

There are number of diagnostic parameters for investigating liver health and function, including bile acids, bilirubinHA, aminotransferases, GLDH and other enzymes.

The liver is the largest solid organ in the body, divided into two unequal lobes: the large right and smaller left.  Each lobe is further divided into thousands of lobules.  The liver is made up of hepatocytes which absorb nutrients and detoxify the blood;  the biliary tract which secretes into the intestines; and the hepatic artery and portal vein which transport nutrients from the intestine.

This hardworking organ has multiple functions including: 

  • LiverCleaning the blood by removing toxins and bacteria
  • Metabolising drugs
  • Manufacturing bile
  • Manufacturing enzymes
  • Manufacturing hormone
  • Storing vitamins, glycogen
  • Releasing glucose
  • Fighting infections

The incidence of liver disease in the UK is rising, primarily as a result of alcohol, fatty liver disease and viral hepatitis.   Liver diseases are often asymptomatic and difficult to detect but there are a number of diagnostic tests that can aid in the diagnosis and monitoring of liver function and disease progression.  Here we present the Alpha portfolio of assays for liver disease screening, diagnosis and monitoring.

Bile Acids for Obstetric Choleostasis

Bile acids are synthesised in the liver and stored in the gallbladder.  When food is consumed bile acids are secreted into the intestine where they facilitate the formation of micelles and promote processing of dietary fat.

Bile Acids Testing can aid diagnosis of cholestasis, portosystemic shunt and bile acids malabsorption.

Raised Bile Acids in pregnancy are indicative of Obstetric Cholestasis, a condition that is associated with foetal distress, premature labour and still birth.  Determination of bile acids can also assist with the diagnosis of other liver diseases and bile acid malabsorption.  Increased bile acids in fasting or postprandial state are considered a specific indicator of liver disease and decreased levels are associated with bile acid malabsorption.

  • bloodKinetic, enzymatic recycling method
  • Use with serum or plasma
  • Suitable for automation
  • Ready-to-use reagents
  • OVS 30 days at 2-8ºC
  • Linearity up to 180µmol/L

 

Bile Acids
Product Code Description Pack Size Price Add to Cart
903115 Bile Acid Total R1: 4 x 45ml, R2: 1 x 60ml £308.00   
903120 Bile Acid Total R1: 4 x 22.5ml, R2: 1 x 30ml £159.00   
D98481SV Diacon Normal Control 1 x 5ml £21.00   
D98482SV Diacon Abnormal Control 1 x 5ml £23.00   
903210 Bile Acid Standard 1 x 3ml £21.00   

  

Bilirubin for Neonatal Jaundice

Bilirubin is a product of haem catabolism.  Small amounts of bilirubin are present in the blood as a result of damaged and dead red blood cells which are disposed of via the spleen. When too many cells are being destroyed or the liver is unable to remove all of the bilirubin from the blood the levels of bilirubin increase and can result in jaundice.

New born babies lack the intestinal bacteria that help process bilirubin and neonatal bilirubineamia is not uncommon.  Typically this resolves itself in a couple of days, but in some instances the newborn's blood may have been destroyed because of blood typing incompatibilities or other genetic factors.   It is important that the levels of bilirubin do not get too high in young babies as excessive bilirubin damages developing brain cells and can cause mental retardation, physical abnormalities or blindness.

Diazo methods for determination of Bilirubin have traditionally been widely used but are prone to interference from haemoglobin, which may result in under reporting, or ascorbic acid which can falsely elevate the test result. The Wako Direct and Total Bilirubin assays use a vanadation oxidation principle and offer excellent performance with minimal interference – giving clear, reliable answers when it matters. 

  • BilirubinNo interference from Ascorbic Acid up to 50 mg/dL
  • No interference from Haemoglobin up to 500mg/dL
  • Ready-to-use reagents
  • OVS 30 days at 2-8ºC
  • Direct Bilirubin: linear to 20mg/dL
  • Total Bilirubin: linear up to 40 mg/dL

 

Bilirubin Direct and Total
Product Code Description Pack Size Price Add to Cart
411-23695 Direct Bilirubin L-Type R1 4 x 70ml £87.00   
413-23895 Direct Bilirubin L-Type R2 4 x 18ml £87.00   
417-23295 Total Bilirubin L-Type R1 4 x 70ml £77.00   
419-23495 Total Bilirubin L-Type R2 4 x 18ml £77.00   
419-73295 Bilirubin Calibrator 4 x 3ml £128.00   

  

Hyaluronic Acid for Liver Fibrosis

There are a number of diseases that can result in liver fibrosis such as viral hepatitis, alcoholism, fatty liver disease or genetic disorders.  Fibrotic injury distorts the normal liver architecture and can result in organ dysfunction and hypertension.  Fibrosis can progress to cirrhosis and also lead to hepatocellular carcinoma (HCC).  Serum Hyaluronic Acid measurement can assist in diagnosis and monitoring of liver fibrosis and cirrhosis.

Hyaluronic Acid is a polysaccharide produced by fibroblasts throughout the body and plays a structural role in the connective tissue matrix.  Whilst high concentrations of HA may be found in connective tissues and joints, serum levels of HA are typically low in healthy individuals as circulating HA is rapidly removed from the blood by sinusoidal endothelial cells (SECs) in the liver.  The HA binds to cell surface receptors and is then endocytosed (internalized) by the cell and degraded.  A strong correlation is seen between serum HA and liver pathology, particularly in cirrhosis, where a reduction in HA receptors on the SECs reduces the rate at which HA can be removed resulting in an increase in circulating HA.

Percutaneous liver biopsy is considered the gold standard for diagnosis and staging liver disease.  However, this invasive procedure is costly and can be problematic, sample limitation may not give conclusive results and the procedure can result in pain, bleeding or even patient death.  Serum Hyaluronic Acid is the current biomarker of choice for liver fibrosis presenting a cost-effective way to distinguish between cirrhosis and earlier stages of fibrosis.   Using a cut-off concentration of 60 ng/ml, HA typically shows a negative predictive value of up to 100% and a positive predictive value of 61% for cirrhosis.

  • HAUse serum or plasma samples
  • Ready-to-use reagents
  • Linearity up to 1000 ng/ml
  • No interference from ascorbic acid, bilirubin or haemoglobin

 

Hyaluronic Acid
Product Code Description Pack Size Price Add to Cart
992-71185 Hyaluronic Acid LT 2 x 15ml, 2 x 6ml £2,304.00   
993-71115 HA Calibrator Set 5 x 2ml £728.00   
998-71165 HA Control Set 2 x (2 x 2ml) £246.00   

  

Hepascore

Whilst HA is the best single marker for liver fibrosis when it comes to distinguishing between the different stages of liver disease a multiparameter approach may be beneficial.  Recent developments have focused on disease modelling using several markers to assist with staging disease.

The Hepascore predictive model uses an algorithm to evaluate four clinical parameters alongside age and sex. 

Each of these parameters is an indicator of liver function but combination of these factors in the Hepascore model augments the predictive value of these non-invasive tests when staging liver disease.

 

Hepascore
Product Code Description Pack Size Price Add to Cart
992-71185 Hyaluronic Acid LT 2 x 15ml, 2 x 6ml £2,304.00   
993-71115 HA Calibrator Set 5 x 2ml £728.00   
998-71165 HA Control Set 2 x (2 x 2ml) £246.00   
411-23695 Direct Bilirubin L-Type R1 4 x 70ml £87.00   
413-23895 Direct Bilirubin L-Type R2 4 x 18ml £87.00   
417-23295 Total Bilirubin L-Type R1 4 x 70ml £77.00   
419-23495 Total Bilirubin L-Type R2 4 x 18ml £77.00   
419-73295 Bilirubin Calibrator 4 x 3ml £128.00   
11018D Alpha 2-Macroglobulin 2 x 50; 2 x 1ml; 1x10ml £97.00   
11200D Plasmaproteins Calibrator 3 x 1ml £87.00   
17336H Gamma GT Liquid 65ml; 18ml £47.00   
16550 Clin Chem Calibrator 4 x 3ml £87.00   

  

Liver Function – Aminotransferase Enzymes

Alanine aminotransferase (ALT) and Aspartate Aminotransferase (AST) are the most important representatives of a group of enzymes which catalyse the conversion of alpha-keto acids into amino acids by transfer of amino groups.

Alanine aminotransferase is an enzyme found predominantly in the liver but smaller amounts are also found in the kidneys, heart and muscles. Under normal conditions levels of ALT in the blood are low but when the liver is damaged ALT is released into the blood stream and can usually be detected before other symptoms of liver damage such as jaundice occur.  Serum ALT, sometimes known as serum glutamic-pyruvic transaminase (SGPT) can help with the diagnosis and monitoring of liver disorders.

Aspartate Aminotransferase (AST) is an enzyme found predominantly in heart and liver and to a lesser extent in other muscles. Measuring serum Aspartate Aminotransferase (AST) also known as serum glutamic-oxalacetic transaminase (SGOT) can be assistance when diagnosing liver disorders and may also be indicative of myocardial infarction, myscle dystrophy or organ damage.

Aminotransferase enzymes can indicate the degree of liver inflammation and elevated levels are seen in hepatitis.   ALT and AST are usually measured together as different ratios of AST:ALT are associated with Wilsons disease, alcoholic liver disease and non alcoholic steatohepatitis

  •  Ready-to-use reagentsLiver Function
  • On board stability 30 days
  • Calibration interval 14 days
  • Use with serum or plasma
  • Assay range 2-300 u/L ALT
  • Assay range 2-300 u/L AST

 

Aminotransferases
Product Code Description Pack Size Price Add to Cart
17613 ALT UV Liquid 6 x 80ml, 4 x 21ml £92.00   
17612 AST UV Liquid 6 x 80ml, 4 x 21ml £72.00   
16550 Clin Chem Cal 4 x 3ml £87.00   
16150 Clin Chem Control 1 6 x 5ml £97.00   
16250 Clin Chem Control 2 6 x 5ml £97.00   

  

ALP and GGT for Bile Duct Disorders

Alkaline Phosphatase (ALP) is an enzyme found in the liver and biliary tract. Enzyme levels are dependent upon age and sex and increase during bone growth in childhood and in pregnancy. Pathological increases in ALP activity is observed in hepatitis, cirrhosis, malignant tumours and bone diseases.  ALP may be of interest to those investigating reproduction, child development, liver disease, bone disease or cancer.

Gamma GT (gamma glutamyltransferase) (GGT) is an enzyme found in high concentrations in renal tissue. In patients with hepatobiliary diseases significant levels of Gamma GT are found in the serum. This hepatic enzyme appears sooner than other enzymes and remains in the plasma for a longer time making its measurement a valuable tool in the diagnosis of such diseases.

ALP and GGT are often measured together and increases in both of these enzymes are seen in cases of obstructive of cholestatic liver disease where bile is not properly transported from the liver due to a blockage of the bile ducts.  Measuring an increase in GGT will also help to confirm that the rise in serum ALP originates from liver injury.

  • Ready-to-use reagentsALP
  • On board stability 30 days
  • Calibration interval 14 days
  • Use with serum or plasma
  • Assay range 6-700 U/L ALP
  • Assay range 2-700 U/L GGT

 

ALP and GGT
Product Code Description Pack Size Price Add to Cart
17308H ALP Liquid 100ml £36.00   
17336H Gamma GT Liquid 65ml; 18ml £47.00   
16550 Clin Chem Cal 4 x 3ml £87.00   
16150 Clin Chem Control 1 6 x 5ml £97.00   
16250 Clin Chem Control 2 6 x 5ml £97.00   

 

GLDH for Perivenular Hepatocyte Damage

Glutamate dehydrogenase (GLDH) is a mitochondrial enzyme that catalyses the conversion of glutamate to 2-oxoglutarate. Whilst glutamate dehydrogenase (GLDH) is found in many tissues throughout the body, serum GLDH originates mainly from hepatocytes in the liver.  

GLDH is concentrated in the mitochondria of perivenular hepatocytes and increased serum GLDH is indicative of damaged or necrotic hepatocytes.  Drug and toxin induced liver damage may affect distinct zones within the organ, Perivenular liver damage resulting Ethanol, tetracarbon monochloride or hypoxia induced perivenular liver damage is associated with increased serum GLDH.

  • Kinetic, DGKC methodLiver
  • Use with serum or plasma
  • Suitable for automation
  • Ready-to-use reagents
  • Linearity up to 120 U/L

 

Glutamate Dehydrogenase
Product Code Description Pack Size Price Add to Cart
D03773 Glutamate Dehydrogenase 5 x 50ml £144.00   
D98485SV DiaCal Auto 1 x 3ml £23.00   
D98481SV Diacon Normal Control 1 x 5ml £21.00   
D98482SV Diacon Abnormal Control 1 x 5ml £23.00